## Abstract ## Background Information about the nature of public reactions to people with Alzheimer's disease (AD) can help reduce stigmatization associated with the disease. ## Objective The aim of this study was to examine emotional reactions to persons with AD, and its correlates. ## Methods
Using smartphones to address the needs of persons with Alzheimer’s disease
✍ Scribed by Nicola Armstrong; Chris Nugent; George Moore; Dewar Finlay
- Book ID
- 107635466
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 311 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0003-4347
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective: The aim of the present study was to assess lay persons' perceptions about the competence of a person with ad and its relationship to social distance. ## Methods: Face-to-face interviews were conducted with a total of 206 jewish israeli adults (mean age = 59.7) using an experimental
Objectives. To report on a Numbers Needed to Treat (NNT) analysis of the literature identi®ed through a systematic review of trials of cholinesterase inhibitors in Alzheimer's Disease. Design. Search of Medline (1966±1998), EMBASE (1994±1999) and Psychlit (1974±1998) using the keywords cholinestera
## Use of MMSE to differentiate Alzheimer's disease from dementia with Lewy bodies Dear Editor Like Dr Ala and his colleagues (Ala et al., 2002), we have encountered patients with pathologically confirmed dementia with Lewy bodies (DLB) who retro-spectively scored < 5 on the Ala MMSE subscore test
## Abstract ## Objective The aim of the present study was to assess family physicians' perceptions about the competence of a person with AD. ## Methods Telephone interviews were conducted with a representative sample of 395 family physicians using an experimental vignette methodology, varying in
## Abstract ## Introduction Memantine is currently the only treatment approved for moderately severe to severe Alzheimer's disease (AD). There is still some discussion as to its place in clinical practice and many UK clinicians are discouraged for economic reasons from prescribing it. We adopt a ‘